The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis

Summary

GBI Research, the leading business intelligence provider, has released its latest research “The Future of Global Vaccines - Market Forecasts to 2015, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis”, which provides insights on the global vaccines sales, volume and price forecasts to 2015. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global vaccines market. The report analyzes the markets for vaccines in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The Scope of this report includes:

• Annualized market data for the global vaccines market from 2000 to 2008, forecast forward to 2015.
• Analysis of the metabolic disorder therapeutics market in the leading geographies of the world. This includes the US, the UK, Germany, France, Italy, Spain, and Japan
• Market characterization data on the global vaccines market including market size, market share and annual cost of vaccination.
• Key drivers and restraints that have a significant impact on the market
• Competitive landscape of the global vaccines market. The key companies studied in this report are Novartis AG, Sanofi Pasteur, Merck & Co, GlaxoSmithKline and Pfizer Inc.
• Key M&A activities and licensing agreements that have taken place between 2008 and 2009 in the global vaccines market.

Reasons to buy

The report will aid business development and marketing executives strategizing their product launches:

• Build effective strategies to launch their pipeline products by identifying potential geographies.
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
• Develop key strategic initiatives by studying the key strategies of top competitors.
• Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
• Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class vaccines with more efficiency and better safety.

Contents

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION


3 GBI RESEARCH REPORT GUIDANCE


4 THE FUTURE OF GLOBAL VACCINES : MARKET OVERVIEW

4.1 Vaccine Preventable Diseases
4.2 Vaccine Manufacturing Process

5 THE FUTURE OF GLOBAL VACCINES: GLOBAL VACCINES MARKET

5.1 Market Forecasts
  5.1.1 Market Share by Disease Sectors
  5.1.2 Market Share by Geography
5.2 Average Cost of Vaccination per Child
5.3 Target Population
  5.3.1 Immunization Coverage
5.4 Unmet Needs
5.5 Market Trends
  5.5.1 Immunization Programs
  5.5.2 Public-Private Partnerships
  5.5.3 Production Capacity
  5.5.4 Reimbursements
5.6 Drivers
  5.6.1 Growth will be Driven by Vaccines Targeting New Diseases
  5.6.2 Adult Vaccines Segment will Provide Significant Boost to Growth of the Market
  5.6.3 Pediatric Combination Vaccines will Continue to Drive Growth
  5.6.4 Availability of Vaccine Technologies That Help Increase Efficacy and Safety will Drive Innovation and Growth
  5.6.5 Cancer and HIV/AIDS Vaccines Hold Significant Potential for the Future
5.7 Barriers
  5.7.1 Limitations in Production Capacity Delays Realization of Potential
  5.7.2 High Initial Capital Investments and Technical Expertise Acts as Entry Barrier
  5.7.3 Lack of Harmonized Regulations Delays Vaccine Launch and Acceptance

6 THE FUTURE OF GLOBAL VACCINES: THE US VACCINES MARKET

6.1 Market Overview
6.2 Market Forecasts
6.3 Average Cost of Vaccination per Child
6.4 Immunization Schedule
6.5 Regulatory Framework
6.6 Vaccine Procurement
6.7 Vaccine Stockpiling

7 THE FUTURE OF GLOBAL VACCINES: EUROPEAN VACCINES MARKET

7.1 Market Overview
7.2 Market Forecasts
7.3 Average Cost of Vaccination per Child
7.4 Vaccine Stockpiling
7.5 The United Kingdom
  7.5.1 Immunization Schedule
  7.5.2 Regulatory Framework
  7.5.3 Vaccine Procurement
7.6 France
  7.6.1 Immunization Schedule
  7.6.2 Regulatory Framework
  7.6.3 Vaccine Procurement
7.7 Germany
  7.7.1 Immunization Schedule
  7.7.2 Regulatory Framework
  7.7.3 Vaccine Procurement
7.8 Italy
  7.8.1 Immunization Schedule
  7.8.2 Regulatory Framework
  7.8.3 Vaccine Procurement
7.9 Spain
  7.9.1 Immunization Schedule
  7.9.2 Regulatory Framework
  7.9.3 Vaccine Procurement

8 THE FUTURE OF GLOBAL VACCINES: REST OF THE WORLD

8.1 Market Overview
8.2 Market Forecasts
8.3 Average Cost of Vaccination per Child
8.4 Immunization Schedule
8.5 Regulatory Framework
8.6 Vaccine Procurement
8.7 Vaccine Stockpiling

9 THE FUTURE OF GLOBAL VACCINES: GLOBAL ROTAVIRUS VACCINES MARKET

9.1 Market Overview
9.2 Market Forecasts
9.3 Average Cost of Vaccination
9.4 Target Population
  9.4.1 Immunization Coverage
9.5 Product Analysis
  9.5.1 RotaTeq
  9.5.2 Rotarix
9.6 Vaccine Pipeline Analysis

10 THE FUTURE OF GLOBAL VACCINES: GLOBAL PNEUMOCOCCAL VACCINES MARKET

10.1 Market Overview
10.2 Market Forecasts
10.3 Average Cost of Vaccination
10.4 Target Population
  10.4.1 Immunization Coverage
10.5 Product Analysis
  10.5.1 Prevnar
  10.5.2 Synflorix
10.6 Vaccine Pipeline Analysis

11 THE FUTURE OF GLOBAL VACCINES: GLOBAL HUMAN PAPILLOMAVIRUS VACCINES MARKET

11.1 Market Overview
11.2 Market Forecasts
11.3 Average Cost of Vaccination
11.4 Target Population
  11.4.1 Immunization Coverage
11.5 Product Analysis
  11.5.1 Gardasil
  11.5.2 Cervarix
11.6 Vaccine Pipeline Analysis
  11.6.1 Profiles of Key Late Stage Vaccines

12 THE FUTURE OF GLOBAL VACCINES: GLOBAL SEASONAL FLU VACCINES MARKET

12.1 Market Overview
12.2 Market Forecasts
12.3 Average Cost of Vaccination
12.4 Target Population
  12.4.1 Immunization Coverage
12.5 Product Analysis
  12.5.1 Fluzone
  12.5.2 Fluarix
12.6 Vaccine Pipeline Analysis
  12.6.1 Profiles of Key Late Stage Vaccines

13 THE FUTURE OF GLOBAL VACCINES: COMPETITIVE LANDSCAPE

13.1 Overview
13.2 Market Share Analysis
13.3 Competitor Profiles
  13.3.1 Sanofi Pasteur MSD
  13.3.2 Merck
  13.3.3 GlaxoSmithKline (GSK)
  13.3.4 Novartis
  13.3.5 Pfizer
  13.3.6 Sanofi Pasteur

14 THE FUTURE OF GLOBAL VACCINES : STRATEGIC CONSOLIDATIONS

14.1 Mergers and Acquisitions
  14.1.1 Pfizer Acquires Wyeth for $68 billion
  14.1.2 BioSante Pharmaceuticals Acquires Cell Gensys
  14.1.3 Johnson & Johnson Acquires 18% Stake in Crucell
14.2 Licensing Agreements
  14.2.1 Discovery Phase
  14.2.2 Phase I
  14.2.3 Phase II
  14.2.4 Phase III
  14.2.5 Filed for Approval and Approved

15 APPENDIX

15.1 Market Definitions
15.2 Key Support Data
15.3 Abbreviations
15.4 Methodology
  15.4.1 Coverage
  15.4.2 Secondary Research
  15.4.3 Primary Research
  15.4.4 Expert Panel Validation
15.5 Contact Us
15.6 Disclaimer


1.1 LIST OF TABLES

Table 1: Vaccines Market, Global, Vaccine Preventable Diseases, 2009
Table 2: Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
Table 3: Vaccines Market, Global, Market Share by Disease Segment, 2009
Table 4: Vaccines Market, Global, Target Population for Pediatric Vaccines, 2007-2016
Table 5: Vaccines Market, Global, Target Population for Adult Vaccines, 2007-2016
Table 6: Vaccines Market, Global, Immunization Coverage for Key Vaccines, 2007-2009
Table 7: Vaccines Market, The US, Revenue Forecasts ($bn), 2007-2016
Table 8: Vaccines Market, The US, Average Cost of Vaccination Per Child ($), 2009
Table 9: Vaccines Market, Europe, Revenue Forecasts ($bn), 2007-2016
Table 10: Vaccines Market, Europe, Average Cost of Vaccination Per Child ($), 2009
Table 11: Vaccines Market, Rest of the World, Revenue Forecasts ($bn), 2007-2016
Table 12: Vaccines Market, Rest of the World, Pandemic and Pre-Pandemic Stockpiling of H5N1 Vaccine, 2009
Table 13: Rotavirus Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
Table 14: Rotavirus Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
Table 15: Rotavirus Vaccines Market, Global, Target Population, 2007-2016
Table 16: Rotavirus Vaccines Market, Global, Comparison of Key Products, 2009
Table 17: Pneumococcal Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
Table 18: Pneumococcal Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
Table 19: Pneumococcal Vaccines Market, Global, Target Population, 2007-2016
Table 20: Pneumococcal Vaccines Market, Global, Comparison of Key Products, 2009
Table 21: HPV Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
Table 22: HPV Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
Table 23: HPV Vaccines Market, Global, Target Population, 2007-2016
Table 24: HPV Vaccines Market, Global, Comparison of Key Products, 2009
Table 25: HPV Vaccines Market, Global, Key Late Stage Vaccine Products, 2009
Table 26: Seasonal Flu Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
Table 27: Seasonal Flu Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
Table 28: Seasonal Flu Vaccines Market, Global, Target Population, 2007-2016
Table 29: Seasonal Flu Vaccines Market, Global, Comparison of Key Products, 2009
Table 30: Seasonal Flu Vaccines Market, Global, Key Late Stage Vaccine Products, 2009
Table 31: Vaccines Market, Global, Top M&A Deals, 2009
Table 32: Vaccines Market, Global, Licensing Deals by Phase, Discovery, 2009
Table 33: Vaccines Market, Global, Licensing Deals by Phase, Phase I, 2009
Table 34: Vaccines Market, Global, Licensing Deals by Phase, Phase II, 2009
Table 35: Vaccines Market, Global, Licensing Deals by Phase, Phase III, 2009
Table 36: Vaccines Market, Global, Licensing Deals by Phase, Filed for Approval, 2009
Table 37: Vaccines Market, Global, Licensing Deals by Phase, Approved, 2009

1.2 LIST OF FIGURES

Figure 1: Vaccines Market, Global, Manufacturing Process, 2009
Figure 2: Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
Figure 3: Vaccines Market, Global, Market Share by Disease Segment, 2009
Figure 4: Vaccines Market, Global, Market Share by Geography, 2009
Figure 5: Vaccines Market, Global, Average Cost of Vaccination by Geography, 2009
Figure 6: Vaccines Market, Global, Target Population for Pediatric Vaccines, 2007-2016
Figure 7: Vaccines Market, Global, Target Population for Adult Vaccines, 2007-2016
Figure 8: Vaccines Market, Global, Immunization Coverage for Key Vaccines, 2007-2009
Figure 9: Vaccines Market, Global, Unmet Needs, 2009
Figure 10: Vaccines Market, Global, Drivers and Barriers, 2009-2016
Figure 11: Vaccines Market, The US, Revenue Forecasts ($bn), 2007-2016
Figure 12: Vaccines Market, The US, Average Cost of Vaccination Per Child ($), 2009
Figure 13: Vaccines Market, The US, Immunization Schedule, 2009
Figure 14: Vaccines Market. The US, Vaccine Development and Approval Process, 2009
Figure 15: Vaccines Market, The US, Distribution of Vaccine Procurement, 2009
Figure 16: Vaccines Market, Europe, Revenue Forecasts ($bn), 2007-2016
Figure 17: Vaccines Market, Europe, Average Cost of Vaccination Per Child ($), 2009
Figure 18: Vaccines Market, The UK, Immunization Schedule, 2009
Figure 19: Vaccines Market, France, Immunization Schedule, 2009
Figure 20: Vaccines Market, France, Distribution of Vaccine Administration by Sector, 2009
Figure 21: Vaccines Market, France, Distribution of Vaccine Reimbursement by Sector, 2009
Figure 22: Vaccines Market, Germany, Immunization Schedule, 2009
Figure 23: Vaccines Market, Germany, Distribution of Vaccine Administration by Sector, 2009
Figure 24: Vaccines Market, Germany, Distribution of Procurement by Sector, 2009
Figure 25: Vaccines Market, Italy, Immunization Schedule, 2009
Figure 26: Vaccines Market, Spain, Immunization Schedule, 2009
Figure 27: Vaccines Market, Spain, Distribution of Healthcare Coverage by Sector, 2009
Figure 28: Vaccines Market, Rest of the World, Revenue Forecasts ($bn), 2007-2016
Figure 29: Vaccines Market, Rest of the World, Average Cost of Vaccination Per Child ($), 2009
Figure 30: Rotavirus Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
Figure 31: Rotavirus Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
Figure 32: Rotavirus Vaccines Market, Global, Target Population, 2007-2016
Figure 33: Pneumococcal Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
Figure 34: Pneumococcal Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
Figure 35: Pneumococcal Vaccines Market, Global, Target Population, 2007-2016
Figure 36: HPV Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
Figure 37: HPV Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
Figure 38: HPV Vaccines Market, Global, Target Population, 2007-2016
Figure 39: Seasonal Flu Vaccines Market, The US, Doses Produced and Distributed, 2000-2008
Figure 40: Seasonal Flu Vaccines Market, The US, Sales by Channel, 2008
Figure 41: Seasonal Flu Vaccines Market, The US, Production Share by Company, 2008
Figure 42: Seasonal Flu Vaccines Market, The US, Market Share by Provider Type , 2007
Figure 43: Seasonal Flu Vaccines Market, The US, Dose Volume (million) , 2009
Figure 44: Seasonal Flu Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
Figure 45: Seasonal Flu Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
Figure 46: Seasonal Flu Vaccines Market, Global, Target Population, 2007-2016
Figure 47: Vaccines Market, Global, Market Share by Company, 2009
Figure 48: Vaccines Market, Global, Comparison of Competitor Revenues by Quarter ($m), 2009
Figure 49: Vaccines Market, Global, Competitive Benchmarking of Top Six Vaccine Players, 2009-2016
Figure 50: Vaccines Market, Global, Competitive Benchmarking of Key Vaccine Markets, 2009-2016
Figure 51: Vaccines Market, Global, Sanofi Pasteur MSD, Sales of Key Product Segments by Quarter, 2009
Figure 52: Vaccines Market, Global, Merck, Sales of Key Product Segments by Quarter, 2009
Figure 53: Vaccines Market, Global, GlaxoSmithKline, Sales of Key Product Segments by Quarter, 2009
Figure 54: Vaccines Market, Global, Novartis, Sales of Key Product Segments by Quarter, 2009
Figure 55: Vaccines Market, Global, Sanofi Pasteur, Sales of Key Product Segments by Quarter, 2009
Figure 56: Vaccines Market, Global, M&A Landscape by Deal Type, 2009
Figure 57: Vaccines Market, Global, M&A Deals by Geography, 2009
Figure 58: Vaccines Market, Global, M&A Deals by Value, 2009
Figure 59: Vaccines Market, Global, Licensing & Alliances by Phase, 2009
Figure 60: Vaccines Market, Global, Licensing & Alliances Geography, 2009
Figure 61: Vaccines Market, Global, Licensing & Alliances by Deal Value, 2009
Figure 62: Vaccines Market, Global, Licensing & Alliances by Indications, 2009
Figure 63: GBI Research Methodology

COMPANIES MENTIONED

Novartis AG
Sanofi Pasteur
Merck & Co
GlaxoSmithKline
Pfizer Inc. Skip to top